Avadel Pharmaceuticals plc (AVDL) DCF Valuation

Avadel Pharmaceuticals plc (AVDL) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Avadel Pharmaceuticals plc (AVDL) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Avadel Pharmaceuticals plc (AVDL) valuation with this customizable DCF Calculator! Featuring real Avadel Pharmaceuticals plc (AVDL) financials and adjustable forecast inputs, you can test scenarios and uncover Avadel Pharmaceuticals plc (AVDL) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 59.2 22.3 .0 .0 28.0 16.6 9.9 5.9 3.5 2.1
Revenue Growth, % 0 -62.28 -100 0 0 -40.57 -40.57 -40.57 -40.57 -40.57
EBITDA -23.6 -35.0 -84.8 -97.6 -149.1 -1.3 -.8 -.5 -.3 -.2
EBITDA, % -39.88 -156.58 100 100 -533.29 -7.98 -7.98 -7.98 -7.98 -7.98
Depreciation 2.5 1.7 .8 1.5 1.8 7.2 4.3 2.6 1.5 .9
Depreciation, % 4.2 7.57 100 100 6.32 43.62 43.62 43.62 43.62 43.62
EBIT -26.1 -36.7 -85.6 -99.1 -150.9 -1.5 -.9 -.5 -.3 -.2
EBIT, % -44.07 -164.15 100 100 -539.61 -8.81 -8.81 -8.81 -8.81 -8.81
Total Cash 64.2 221.4 157.2 96.5 105.1 16.6 9.9 5.9 3.5 2.1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 8.3 3.3 .0 .0 13.4
Account Receivables, % 13.98 14.89 100 100 48.01
Inventories 3.6 .0 .0 .0 10.4 8.1 4.8 2.9 1.7 1.0
Inventories, % 6.03 0 100 100 37.12 48.63 48.63 48.63 48.63 48.63
Accounts Payable 6.1 2.9 7.7 7.9 11.4 8.8 5.2 3.1 1.8 1.1
Accounts Payable, % 10.3 13.14 100 100 40.89 52.86 52.86 52.86 52.86 52.86
Capital Expenditure .0 -.1 .0 -.7 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -0.04897408 -0.43879 100 100 0 -0.09755339 -0.09755339 -0.09755339 -0.09755339 -0.09755339
Tax Rate, % 0.31161 0.31161 0.31161 0.31161 0.31161 0.31161 0.31161 0.31161 0.31161 0.31161
EBITAT -22.5 50.7 -71.1 -122.2 -150.4 -1.1 -.6 -.4 -.2 -.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -25.8 57.7 -62.2 -121.3 -168.9 10.0 7.1 4.2 2.5 1.5
WACC, % 12.63 11.66 12.6 12.79 12.78 12.49 12.49 12.49 12.49 12.49
PV UFCF
SUM PV UFCF 19.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 2
Terminal Value 14
Present Terminal Value 8
Enterprise Value 28
Net Debt 4
Equity Value 24
Diluted Shares Outstanding, MM 80
Equity Value Per Share 0.30

What You Will Receive

  • Genuine Avadel Data: Preloaded financials – encompassing revenue to EBIT – derived from actual and projected figures.
  • Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
  • Immediate Valuation Adjustments: Automatic recalculations to evaluate the effects of changes on Avadel’s fair value.
  • Flexible Excel Template: Designed for quick modifications, scenario analysis, and in-depth projections.
  • Efficient and Precise: Avoid the hassle of building models from the ground up while ensuring accuracy and adaptability.

Key Features

  • Comprehensive AVDL Data: Includes Avadel Pharmaceuticals' historical financial performance and future projections.
  • Fully Customizable Inputs: Tailor revenue growth, profit margins, discount rates, tax implications, and capital investments.
  • Dynamic Valuation Model: Instantaneous updates to Net Present Value (NPV) and intrinsic value based on your specified inputs.
  • Scenario Testing: Develop various forecast scenarios to evaluate different valuation results.
  • User-Friendly Design: Intuitive, organized, and suitable for both professionals and novices.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Avadel Pharmaceuticals data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Avadel Pharmaceuticals' intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose Avadel Pharmaceuticals plc (AVDL)?

  • Innovative Solutions: Cutting-edge therapies designed to meet unmet medical needs.
  • Proven Track Record: A history of successful product development and market introduction.
  • Patient-Centric Approach: Commitment to improving patient outcomes and quality of life.
  • Expert Team: A dedicated group of professionals with extensive industry experience.
  • Strong Partnerships: Collaborations with leading organizations to enhance research and development.

Who Should Use Avadel Pharmaceuticals plc (AVDL)?

  • Investors: Gain insights and make informed decisions with a reliable resource on Avadel's market performance.
  • Financial Analysts: Streamline your analysis with comprehensive data and reports tailored for Avadel Pharmaceuticals.
  • Consultants: Easily modify and present valuable information about Avadel to your clients.
  • Healthcare Enthusiasts: Explore the latest developments in pharmaceuticals and their impact on Avadel's growth.
  • Educators and Students: Utilize this information as a case study in pharmaceutical finance and industry trends.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations.
  • Real-World Data: Avadel Pharmaceuticals plc’s (AVDL) historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Charts and tables providing clear, actionable results.

No products were found matching.